Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

Similar articles for PubMed (Select 23765536)

1.

Low RIN1 expression in HCC is associated with tumor invasion and unfavorable prognosis.

He H, Wu G, Liu H, Cheng Y, Yu Y, Wang Y, Liu Y.

Am J Clin Pathol. 2013 Jul;140(1):73-81. doi: 10.1309/AJCPEGWYDD86WWJK.

2.

[RIN1 expression in hepatocellular cancer and the affection on prognosis and tumor invasion ability].

Liu HY, Wu G, He H, Wang YW, Cheng Y, Liu YF.

Zhonghua Wai Ke Za Zhi. 2013 Nov;51(11):1025-9. Chinese.

PMID:
24444690
3.

Overexpressed HDGF as an independent prognostic factor is involved in poor prognosis in Chinese patients with liver cancer.

Zhou Y, Zhou N, Fang W, Huo J.

Diagn Pathol. 2010 Sep 16;5:58. doi: 10.1186/1746-1596-5-58.

4.

Overexpression of HOXA1 correlates with poor prognosis in patients with hepatocellular carcinoma.

Zha TZ, Hu BS, Yu HF, Tan YF, Zhang Y, Zhang K.

Tumour Biol. 2012 Dec;33(6):2125-34. doi: 10.1007/s13277-012-0472-6. Epub 2012 Aug 4.

PMID:
22864671
5.

Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.

Zhao JJ, Pan K, Li JJ, Chen YB, Chen JG, Lv L, Wang DD, Pan QZ, Chen MS, Xia JC.

PLoS One. 2011;6(10):e26608. doi: 10.1371/journal.pone.0026608. Epub 2011 Oct 19.

6.

High ADAM8 expression is associated with poor prognosis in patients with hepatocellular carcinoma.

Zhang Y, Tan YF, Jiang C, Zhang K, Zha TZ, Zhang M.

Pathol Oncol Res. 2013 Jan;19(1):79-88. doi: 10.1007/s12253-012-9560-6. Epub 2012 Sep 12.

PMID:
22965687
7.

NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.

Cheng J, Xie HY, Xu X, Wu J, Wei X, Su R, Zhang W, Lv Z, Zheng S, Zhou L.

Cancer Lett. 2011 Nov 1;310(1):35-45. doi: 10.1016/j.canlet.2011.06.001. Epub 2011 Jun 24.

PMID:
21763068
8.

Dyskerin overexpression in human hepatocellular carcinoma is associated with advanced clinical stage and poor patient prognosis.

Liu B, Zhang J, Huang C, Liu H.

PLoS One. 2012;7(8):e43147. doi: 10.1371/journal.pone.0043147. Epub 2012 Aug 13.

9.

Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.

Tu K, Dou C, Zheng X, Li C, Yang W, Yao Y, Liu Q.

BMC Cancer. 2014 Dec 12;14:938. doi: 10.1186/1471-2407-14-938.

10.

Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma.

Wu X, Chen H, Gao Q, Bai J, Wang X, Zhou J, Qiu S, Xu Y, Shi Y, Wang X, Zhou J, Fan J.

Mol Carcinog. 2014 Apr;53(4):325-36. doi: 10.1002/mc.21981. Epub 2012 Nov 20.

PMID:
23169062
11.

Low expression of DAB2IP contributes to malignant development and poor prognosis in hepatocellular carcinoma.

Zhang X, Li N, Li X, Zhao W, Qiao Y, Liang L, Ding Y.

J Gastroenterol Hepatol. 2012 Jun;27(6):1117-25. doi: 10.1111/j.1440-1746.2011.07049.x.

PMID:
22168621
12.

Down-regulated KLF17 expression is associated with tumor invasion and poor prognosis in hepatocellular carcinoma.

Liu FY, Deng YL, Li Y, Zeng D, Zhou ZZ, Tian DA, Liu M.

Med Oncol. 2013 Mar;30(1):425. doi: 10.1007/s12032-012-0425-3. Epub 2013 Jan 17.

PMID:
23325444
13.

Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma.

Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY.

J Gastroenterol Hepatol. 2012 Jan;27(1):173-80. doi: 10.1111/j.1440-1746.2011.06847.x.

PMID:
21777276
14.

The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.

Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W.

Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17.

PMID:
22588469
15.

Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma.

Zhou ZJ, Dai Z, Zhou SL, Fu XT, Zhao YM, Shi YH, Zhou J, Fan J.

Int J Cancer. 2013 Mar 1;132(5):1080-9. doi: 10.1002/ijc.27742. Epub 2012 Aug 7.

PMID:
22821376
16.

Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis.

Wang Q, Tan YX, Ren YB, Dong LW, Xie ZF, Tang L, Cao D, Zhang WP, Hu HP, Wang HY.

BMC Cancer. 2011 Jun 25;11:271. doi: 10.1186/1471-2407-11-271.

17.

Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma.

Cui J, Yu Y, Lu GF, Liu C, Liu X, Xu YX, Zheng PY.

Tumour Biol. 2013 Jun;34(3):1913-8. doi: 10.1007/s13277-013-0735-x. Epub 2013 Mar 21.

PMID:
23516026
18.

Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.

Chua MS, Sun H, Cheung ST, Mason V, Higgins J, Ross DT, Fan ST, So S.

Mod Pathol. 2007 Jan;20(1):76-83. Epub 2006 Sep 29.

19.

LAPTM4B-35 overexpression is a risk factor for tumor recurrence and poor prognosis in hepatocellular carcinoma.

Yang H, Xiong FX, Lin M, Yang Y, Nie X, Zhou RL.

J Cancer Res Clin Oncol. 2010 Feb;136(2):275-81. doi: 10.1007/s00432-009-0659-4. Epub 2009 Aug 19.

PMID:
19690886
20.

Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.

Zhang G, Liu T, Wang Z.

J Invest Surg. 2012 Apr;25(2):93-9. doi: 10.3109/08941939.2011.606875. Epub 2011 Sep 26.

PMID:
21942217
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk